Computational molecular modelling as a platform for a deeper understanding of protein dynamics and rational drug design


https://doi.org/10.4081/bse.87
Vol. 1 No. 1 (2020)
Published: 11 February 2020
Molecular modelling, drug design neurodegenerative, protein folding
Abstract views:
570


PDF:
272
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

  • Gianvito Grasso Istituto Dalle Molle di Studi sull’Intelligenza Artificiale (IDSIA), Scuola Universitaria Professionale della Svizzera Italiana (SUPSI), Università della Svizzera Italiana (USI), Centro Galleria 2, Manno, Switzerland.
  • Lorenzo Pallante Department of Mechanical and Aerospace Engineering, Politecnico di Torino, Turin, Italy.
  • Jack A. Tuszynski Department of Mechanical and Aerospace Engineering, Politecnico di Torino, Turin, Italy.
  • Umberto Morbiducci Department of Mechanical and Aerospace Engineering, Politecnico di Torino, Turin, Italy.
  • Marco A. Deriu
    marco.deriu@polito.it
    Department of Mechanical and Aerospace Engineering, Politecnico di Torino, Turin, Italy.

Elucidating structural features of protein aggregation at molecular level may provide novel opportunities for overarching therapeutic approaches such as blocking common aggregation-induced cellular toxicity pathways. In this context molecular modelling stimulates further research on amyloid aggregation modulators and modelling platforms can be used to test the efficiency of potential aggregation inhibitors aimed at destabilizing/reducing the stability of the amyloidogenic proteins


Lorenzo Pallante, Department of Mechanical and Aerospace Engineering, Politecnico di Torino, Turin

-

Grasso, G., Pallante, L., Tuszynski, J. A., Morbiducci, U., & Deriu, M. A. (2020). Computational molecular modelling as a platform for a deeper understanding of protein dynamics and rational drug design. Biomedical Science and Engineering, 1(1). https://doi.org/10.4081/bse.87

Copyright (c) 2019 The Authors

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Most read articles by the same author(s)

Similar Articles

You may also start an advanced similarity search for this article.